The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2024 | Limitations to using artificial intelligence for imaging in lung cancer
Xiuyuan Chen, MD, Peking University People’s Hospital, Beijing, China, comments on potential issues surrounding the use of artificial intelligence (AI) for imaging in lung cancer. Additional research is needed to validate their utility in the clinic. Whilst AI can extract information from CAT scans, studies need to prove the data is of clinical use for healthcare professionals and patients. This interview took place at the 2024 World Conference on Lung Cancer (WCLC) in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
